West Pharmaceutical (WST) Tops Q4 EPS by 5c; Issues Strong FY13 Outlook

Article Related Press Releases (1) Stock Quotes (1) Comments (0)

West Pharmaceutical Services, Inc. (NYSE: WST) reported Q4 EPS of $0.61, $0.05 better than the analyst estimate of $0.56. Revenue for the quarter came in at $321.5 million versus the consensus estimate of $318.75 million.

West Pharmaceutical Services, Inc. sees FY2013 EPS of $2.97-3.17, versus the consensus of $3.00. West Pharmaceutical Services, Inc. sees FY2013 revenue of $1.36-1.40 billion, versus the consensus of $1.32 billion.

For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
• UPDATE: Solarcity (SCTY) Posts Q1 GAAP Loss of 41c/Share
• Hollsys (HOLI) Tops Q3 EPS by 1c; Lowers FY13 Outlook

Create E-mail Alert Related Categories

Earnings, Guidance

Related Entities

Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?